These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 34107578

  • 1. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
    Duan SP, Zhu LH, Hou LJ, Wang HW, Zhu XW, Hao J.
    Zhonghua Gan Zang Bing Za Zhi; 2021 May 20; 29(5):421-426. PubMed ID: 34107578
    [Abstract] [Full Text] [Related]

  • 2. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.
    Gastroenterology; 2019 Jul 20; 157(1):227-241.e7. PubMed ID: 30930022
    [Abstract] [Full Text] [Related]

  • 3. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis].
    Shi H, Li XY, Zhu JY, Lin CS, Zhang Y.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct 20; 25(10):721-725. PubMed ID: 29108198
    [Abstract] [Full Text] [Related]

  • 4. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
    Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L.
    World J Gastroenterol; 2015 May 14; 21(18):5524-31. PubMed ID: 25987775
    [Abstract] [Full Text] [Related]

  • 5. The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy.
    Hu X, Luo H, Tan G, Li Y, Qin B.
    BMC Gastroenterol; 2023 May 19; 23(1):163. PubMed ID: 37208599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW, Gurel S, Caruntu FA, Flaherty JF, Massetto B, Dinh P, Corsa A, Subramanian GM, McHutchison JG, Husa P, Gane E.
    Gastroenterology; 2014 Apr 19; 146(4):980-8. PubMed ID: 24368224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
    Berg T, Simon KG, Mauss S, Schott E, Heyne R, Klass DM, Eisenbach C, Welzel TM, Zachoval R, Felten G, Schulze-Zur-Wiesch J, Cornberg M, Op den Brouw ML, Jump B, Reiser H, Gallo L, Warger T, Petersen J, FINITE CHB study investigators [First investigation in stopping TDF treatment after long-term virological suppression in HBeAg-negative chronic hepatitis B].
    J Hepatol; 2017 Nov 19; 67(5):918-924. PubMed ID: 28736139
    [Abstract] [Full Text] [Related]

  • 10. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY, Lin BL, Chen FJ, Deng H, Chong YT, Zhang XH, Gao ZL.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep 19; 18(9):646-50. PubMed ID: 20943073
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of the efficacy of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B combined with nonalcoholic fatty liver disease by high-sensitivity detection of HBV DNA levels].
    Liang CG, Wang X, Liu SH, Shi XF.
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb 20; 31(2):113-117. PubMed ID: 37137824
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone.
    Lin S, Fu Y, Wu W, Chen T, Chen N, Xun Z, Liu C, Ou Q, Zeng Y, Huang H.
    Int J Med Sci; 2020 Feb 20; 17(10):1458-1463. PubMed ID: 32624702
    [Abstract] [Full Text] [Related]

  • 14. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.
    Kim JH, Jung SW, Byun SS, Shin JW, Park BR, Kim MH, Kim CJ, Park NH.
    Int J Clin Pharm; 2015 Dec 20; 37(6):1228-34. PubMed ID: 26364195
    [Abstract] [Full Text] [Related]

  • 16. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B.
    N Engl J Med; 2016 Jun 16; 374(24):2324-34. PubMed ID: 27305192
    [Abstract] [Full Text] [Related]

  • 17. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HLA, Gane E, Sozzi V, Colledge D, Hammond R, Edwards R, Locarnini S, Thompson A, Revill PA.
    Gut; 2017 Nov 16; 66(11):2013-2023. PubMed ID: 27534671
    [Abstract] [Full Text] [Related]

  • 18. Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.
    Li J, Qu L, Sun X, Liu Y, Gong Q, Yu D, Zhang D, Jiang J, Chen J, Wei D, Han Y, Gao Y, Zhang Q, She W, Chen L, Zhang J, Zhang X.
    J Viral Hepat; 2021 Oct 16; 28(10):1381-1391. PubMed ID: 34228855
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.